Tal Nuriel, PhD

Tal Nuriel is a postdoctoral research fellow at the Columbia University Medical Center (CUMC). He earned his bachelor's degree at the University of Michigan where, as part of the university's Undergraduate Research Opportunities Program, he worked in the Brain Tumor Research Laboratory. Next, Dr. Nuriel worked for three years as a research technician in the laboratory of Moses Chao,PhD, at New York University's Skirball Institute of Biomolecular Medicine, where he focused on multiple sclerosis and other neuropathological disorders. Dr. Nuriel then began his graduate work at Weill Cornell Medical College, where he worked in the laboratory of Steven Gross, PhD, focusing mainly on proteomics and developing novel applications to identify protein modifications caused by oxidative and nitrosative stress in disorders such as Alzheimer's disease. During his time in Dr. Gross’s laboratory, Dr. Nuriel published numerous research articles and was awarded an F31 NRSA fellowship from the National Institute on Aging. After graduate school, he decided to focus his energies on understanding the mechanisms and potential treatments of Alzheimer's disease, and was excited to receive a postdoctoral position at CUMC in the laboratory of Karen Duff, PhD, a recognized leader in the Alzheimer's field. Currently, in her laboratory, Dr. Nuriel is using cutting-edge omics technology (a new biological field aimed at charting the role of molecules within organisms) to understand the role of the apoE4 protein in promoting Alzheimer's disease. By performing the experiments outlined in this grant, Dr. Nuriel hopes to make significant contributions to the Alzheimer's field that will increase our chances of finding effective treatments for Alzheimer's disease in the near future.